COMMUNIQUÉS West-GlobeNewswire

Corporate Update, August 2025
04/08/2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- From Dr. Neil Maresky, CEO, Psyence BioMed (NASDAQ: PBM) Dear Shareholders, Thank you for your continued support as we advance our mission to develop safe, effective, and [...]
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer
04/08/2025
Experienced commercial leader to shape launch strategy and global market readiness for telitacicept and future pipeline opportunities CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical [...]
Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program
04/08/2025
70% of Noom members receiving microdoses of GLP-1 with lifestyle support report no side effects, while experiencing significant weight loss and overall health gains The program addresses all three major barriers to [...]
AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval
04/08/2025
Primary focus on pancreatic cancer Mid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca’s Imfinzi® (durvalumab) for the treatment of pancreatic cancer demonstrates positive signs of both no [...]
New Way to Take Iron: IBSA Launches Innovative Orally Dissolving Film Supplement That’s Gentle on the Stomach and Easy to Take
04/08/2025
WATFORD, United Kingdom, Aug. 04, 2025 (GLOBE NEWSWIRE) -- A new generation of vitamin supplementation has arrived in the UK. IBSA, the Swiss-based pharmaceutical company, has launched a groundbreaking Iron [...]
The Ensign Group Grows in Iowa
04/08/2025
SAN JUAN CAPISTRANO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Adds Real Estate and Operations in Wisconsin
04/08/2025
SAN JUAN CAPISTRANO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Announces Expansion in California
04/08/2025
SAN JUAN CAPISTRANO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter
04/08/2025
SUNNYVALE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today [...]
AB Science annonce le succès d’un placement privé d’environ 2,55 millions d’euros
04/08/2025
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES D’UN PLACEMENT PRIVE D’ENVIRON 2,55 MILLIONS D’EUROS Paris, 4 août 2025, 8h AB Science S.A. (la “ Société ” ou “ AB Science ”, Euronext – FR0010557264 – AB) annonce [...]
AB Science announces the successful completion of a 2.55 million euros private placement
04/08/2025
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 2.55 MILLION PRIVATE PLACEMENT Paris, August 4, 2025, 8am CET AB Science S.A. (the “ Company ” or “ AB Science ”, Euronext – FR0010557264 – AB) [...]
EssilorLuxottica: Avec l’acquisition d’Automation & Robotics, EssilorLuxottica progresse dans les solutions de haute performance pour la production en optique ophtalmique
04/08/2025
Avec l’acquisition d’Automation & Robotics, EssilorLuxottica progresse dans les solutions de haute performance pour la production en optique ophtalmique Paris, France (4 août 2025) – EssilorLuxottica a annoncé [...]
EssilorLuxottica: EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing
04/08/2025
EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing Paris, France (4 August 2025) – EssilorLuxottica announces today the acquisition of Automation & [...]
Pharming Group to participate in August investor conference
04/08/2025
Leiden, the Netherlands, August 4, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month [...]
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
04/08/2025
RADNOR, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp® Simulator for use in regulatory [...]
Financière de Tubize - Rapport financier semestriel 2025
02/08/2025
Rapport financier semestriel 2025 Information réglementée - 2 août 2025 Le conseil d’administration de la Financière de Tubize a établi le rapport financier semestriel 2025. Ce rapport est disponible sur le site [...]
Financière de Tubize - 2025 half-year financial report
02/08/2025
Half-year financial report 2025 Regulated information 2 August 2025 The board of directors of Financière de Tubize has established the 2025 half-year report. This report is available on the website www.financiere-tubize [...]
Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion
01/08/2025
Funds will support advancement of Tevogen.AI, the Company’s artificial intelligence–driven drug discovery initiative. The $1 million is part of up to $10 million in previously announced non ‑ dilutive grant funding from [...]
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
01/08/2025
WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a [...]

Pages